デフォルト表紙
市場調査レポート
商品コード
1334225

神経リハビリ機器の世界市場

Neurorehabilitation Devices

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 504 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
神経リハビリ機器の世界市場
出版日: 2023年08月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 504 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

神経リハビリ機器の世界市場は2030年までに45億米ドルに達する

変化するポストCOVID-19のビジネス環境において、2022年に14億米ドルと予測される神経リハビリ機器の世界市場は、2030年までに45億米ドルの市場規模に改定され、分析期間2022-2030年に16.3%のCAGRで成長すると予測されます。本レポートで分析したセグメントの1つである神経ロボットシステムは、CAGR 18.6%を記録し、分析期間終了時には20億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、ブレイン・コンピュータ・インターフェイス分野の成長は、今後8年間のCAGRを12.3%に修正しました。

米国市場は4億9,430万米ドル、中国はCAGR 21.2%で成長すると予測

米国の神経リハビリ機器市場は、2022年には4億9,430万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年のCAGR21.2%で、2030年までに6億2,820万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ12%と16%の成長が予測されています。欧州では、ドイツがCAGR約14.7%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋地域の市場は、2030年までに4億8,070万米ドルに達すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16626

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neurorehabilitation Devices Market to Reach $4.5 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neurorehabilitation Devices estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$4.5 Billion by 2030, growing at a CAGR of 16.3% over the analysis period 2022-2030. Neurorobotic Systems, one of the segments analyzed in the report, is projected to record a 18.6% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Brain Computer Interface segment is readjusted to a revised 12.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $494.3 Million, While China is Forecast to Grow at 21.2% CAGR

The Neurorehabilitation Devices market in the U.S. is estimated at US$494.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$628.2 Million by the year 2030 trailing a CAGR of 21.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12% and 16% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$480.7 Million by the year 2030.

Select Competitors (Total 105 Featured) -

  • Abbott Laboratories
  • AlterG, Inc.
  • Biometrics Ltd.
  • Bioness Inc.
  • BIONIK Laboratories Corp.
  • Boston Scientific Corporation
  • Ectron Ltd
  • Ekso Bionics Holdings Inc.
  • Eodyne
  • Helius Medical Technologies
  • Hocoma AG
  • Instead Technologies Ltd.
  • Kinestica
  • Medtronic plc
  • Neofect
  • Neuro Rehab VR
  • Reha Technology AG
  • Rehab-Robotics Company Limited.
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd
  • Saebo, Inc.
  • Tyromotion GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Neurological Disorders and Disability - A Prelude
    • Role of Neurorehabilitation in Enhancing Life Quality and Physical Function
    • An Insight into Neurorehabilitation Devices
    • Global Economic Update
    • World Shifts to an Endemic COVID-19 Strategy with Focus on Multilateral Approach to Managing Future Pandemics
    • War, Inflation & High Cost of Living Crisis Supersede COVID-19 as Major Downside Risks for the Global Economy in 2022 & Beyond
    • World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023
    • Neurorehabilitation Devices Market Adversely Impacted by COVID-19
    • Competitive Landscape
    • Neurorehabilitation Devices - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Market Prospects and Outlook
    • Global Neurorehabilitation Devices Market Radiates Signs of Vim & Vigor
    • Neurorehabilitation Remains Dynamic Domain with Progressive Advancements
    • Neuro-Robotic Devices: Thriving Segment of Neurorehabilitation Devices Market
    • Opportunity: Rising Uptake of Robotic Devices
    • Stroke Leads the End-uses of Neurorehabilitation Devices
    • North America Claims Authoritative Stake in Neurorehabilitation Devices Market
    • Immense Burden of Neurological Conditions in US Paves Way for Neurorehabilitation Devices
    • Asia-Pacific to Offer Lucrative Opportunities
    • Technological Advancements Drive Market Growth
    • Neurorehabilitation Becomes a Hotbed for VR & Robotic Technologies
    • Market Restraints
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neurological Conditions Drive Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Epilepsy Incidence Worldwide by Type: Percentage Breakdown for Idiopathic and Symptomatic Epilepsy by Type (2022))
    • Symptomatic Epilepsy Incidence: Percentage of Incidence by Type for 2022
    • Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Adoption of Neurorobotic Systems
    • Exoskeleton Robots Add Sophistication in Neurorehabilitation
    • The Imminent Rise of Exosuits
    • Innovative Exosuits Wearable Robots Promise Accelerated Recovery of Stroke Patients
    • Robotic Exoskeletons as Game-Changing Development for Neurorehabilitation
    • AI Augments Prosthetic Technology
    • Researchers Develop Neurorobotic Prosthetic Arm to Restore Natural Brain Behaviors
    • Select Robotic Devices
    • Robot-assisted Therapy Vs Other Therapies
    • Limitations
    • Technological Developments
    • New Generation Robotic Neurorehabilitation Devices Powered by Non-invasive Brain Machine Interfaces
    • Brain Stimulators Seek to Widen their Role in Neurorehabilitation
    • Global Alzheimer's Prevalence by Age Group: 2020
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Global DBS Market by Leading Player (2022): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • Innovative Multi-Electrodes with Potential to Improve Spinal Cord Stimulation
    • Non-Invasive Brain Stimulation
    • Innovative Multi-electrode Stimulation Paves Way for Recovery from Spinal Cord Injuries
    • Neurorehabilitation Therapy in Epilepsy Care
    • Neurorehabilitation Wearable Devices Market Set to Deliver Stunning Performance
    • Novel Wristbands: A Primary Market Driver
    • Wearable Robotic Devices for Neurorehabilitation
    • Wearable Devices Set to Transform Traditional Approaches to Neurorehabilitation of Stroke Patients
    • Primary Wearable Sensors for Stroke Patients
    • Robotic Neurorehabilitation & Noninvasive Brain-Machine Interface to Aid Rehabilitation
    • Brain-Machine Interfaces
    • Key Applications of Virtual Reality for Neurological Rehabilitation
    • VR-Centric Gamification in Neurorehabilitation Improves Outcomes for Stroke Patients
    • Start-ups Leveraging VR for Gamification in Stroke Patient Rehabilitation
    • Technological Advancements in Neuroimaging Techniques Enhance Neurorehabilitation Outcome
    • Advancements in Robotics and Neuroscience Research Give Rise to Next-Generation Rehabilitation Techniques
    • IoT-Powered Rehabilitation Robotics
    • Integration Of Speech Recognition Algorithms
    • Emergence of Novel Multi-electrode Stimulation for Treatment of Spinal Cord Injuries
    • Startups Eye on Affordable Solutions to Spur Neurorehabilitation Uptake across Low- & Middle-Income Nations
    • Tailored and Affordable Neurorehab Technologies
    • Smartphone Technology to Support Neurorehabilitation
    • AR's role in Neurorehabilitation Recovery and Assessment
    • AR Augments the Existing Neurorehabilitation Programs
    • Electrotherapy Emerges a Mega Trend in Neuromuscular Rehabilitation Space
    • Why Metaverse Technology is Soaking Limelight for Holistic Neurological Rehabilitation
    • Neurological Disorders that Could Benefit from Metaverse
    • Moving from Mono-Therapeutic to Holistic Neurorehabilitation with Metaverse
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurorehabilitation Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurorehabilitation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurorobotic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurorobotic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Neurorobotic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Brain Computer Interface by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Brain Computer Interface by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Brain Computer Interface by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Wearable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Brain Stimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Parkinson`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Brain & Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Brain & Spinal Cord Injury by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Brain & Spinal Cord Injury by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cerebral Palsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cerebral Palsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cerebral Palsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Neurorehabilitation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: France 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Neurorehabilitation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • INDIA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: India 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: India 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Neurorehabilitation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Neurorehabilitation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Neurorehabilitation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030
  • AFRICA
    • Neurorehabilitation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Neurorehabilitation Devices by Product - Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Neurorehabilitation Devices by Product - Percentage Breakdown of Value Sales for Neurorobotic Systems, Brain Computer Interface, Wearable Devices and Brain Stimulators for the Years 2014, 2023 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Neurorehabilitation Devices by Application - Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Neurorehabilitation Devices by Application - Percentage Breakdown of Value Sales for Stroke, Parkinson`s Disease, Brain & Spinal Cord Injury, Cerebral Palsy, Multiple Sclerosis and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION